Malabsorption des acides biliaires (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Malabsorption des acides biliaires" in French language version.

refsWebsite

Global rank French rank

20nih.gov

4^th place

12^th place

17doi.org

2^nd place

3^rd place

1nice.org.uk

3,258^th place

low place

1clinicaltrials.gov

5,225^th place

6,624^th place

clinicaltrials.gov

(en) « To Assess Safety, Tolerability and Efficacy of LJN452 in Patients With Primary Bile Acid Diarrhea. - Full Text View - ClinicalTrials.gov », clinicaltrials.gov (consulté le 9 avril 2018)

doi.org

dx.doi.org

(en) Thaysen et Pedersen, L, « Idiopathic bile acid catharsis », Gut, vol. 17, n^o 12,‎ 1976, p. 965–70 (PMID 1017717, PMCID 1411224, DOI 10.1136/gut.17.12.965)
(en) Dawson, Lan, T et Rao, A, « Bile acid transporters », Journal of Lipid Research, vol. 50, n^o 12,‎ 2009, p. 2340–57. (PMID 19498215, PMCID 2781307, DOI 10.1194/jlr.R900012-JLR200)
(en) Oelkers, Kirby, LC, Heubi, JE et Dawson, PA, « Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2) », The Journal of Clinical Investigation, vol. 99, n^o 8,‎ 1997, p. 1880–7. (PMID 9109432, PMCID 508012, DOI 10.1172/JCI119355)
(en) Montagnani, Love, MW, Rössel, P et Dawson, PA, « Absence of dysfunctional ileal sodium-bile acid cotransporter gene mutations in patients with adult-onset idiopathic bile acid malabsorption », Scandinavian Journal of Gastroenterology, vol. 36, n^o 10,‎ 2001, p. 1077–80. (PMID 11589382, DOI 10.1080/003655201750422693)
(en) Hofmann, « Chronic diarrhea caused by idiopathic bile acid malabsorption: an explanation at last », Expert Review of Gastroenterology & Hepatology, vol. 3, n^o 5,‎ 2009, p. 461–4. (PMID 19817666, DOI 10.1586/egh.09.49)
(en) Walters, Tasleem, AM, Omer, O S et Brydon, WG, « A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis », Clinical Gastroenterology and Hepatology, vol. 7, n^o 11,‎ 2009, p. 1189–94. (PMID 19426836, DOI 10.1016/j.cgh.2009.04.024)
(en) « Methods for diagnosis of bile acid malabsorption in clinical practice », Clin. Gastroenterol. Hepatol., vol. 11, n^o 10,‎ 2013, p. 1232–9. (PMID 23644387, PMCID 3783593, DOI 10.1016/j.cgh.2013.04.029)
(en) « Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome », Aliment. Pharmacol. Ther., vol. 30, n^o 7,‎ 2009, p. 707–17. (PMID 19570102, DOI 10.1111/j.1365-2036.2009.04081.x)
(en) Walters, « Defining primary bile acid diarrhea: making the diagnosis and recognizing the disorder », Expert Review of Gastroenterology & Hepatology, vol. 4, n^o 5,‎ 2010, p. 561–7. (PMID 20932141, DOI 10.1586/egh.10.54)
Khalid, Lalji, A, Stafferton, R et Andreyev, J, « Bile acid malabsorption: a forgotten diagnosis? », Clinical Medicine, vol. 10, n^o 2,‎ 2010, p. 124–6. (PMID 20437979, DOI 10.7861/clinmedicine.10-2-124)
(en) Brydon, Nyhlin, H, Eastwood, MA et Merrick, MV, « Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea », European Journal of Gastroenterology & Hepatology, vol. 8, n^o 2,‎ 1996, p. 117–23. (PMID 8723414, DOI 10.1097/00042737-199602000-00005)
(en) « Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention », Aliment. Pharmacol. Ther., vol. 38, n^o 8,‎ 2013, p. 967–76. (PMID 23981126, DOI 10.1111/apt.12466)
(en) Valentin, Camilleri, Altayar et Vijayvargiya, « Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis », Gut, vol. 65, n^o 12,‎ décembre 2016, p. 1951–9. (PMID 26347530, DOI 10.1136/gutjnl-2015-309889)
(en) « Systematic review: the management of chronic diarrhoea due to bile acid malabsorption », Aliment. Pharmacol. Ther., vol. 39, n^o 9,‎ mai 2014, p. 923–39. (PMID 24602022, DOI 10.1111/apt.12684)
(en) Wedlake, Thomas, K, Lalji, A et Anagnostopoulos, C, « Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire », Clinical Therapeutics, vol. 31, n^o 11,‎ 2009, p. 2549–58. (PMID 20109999, DOI 10.1016/j.clinthera.2009.11.027)
(en) « Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn's disease: A randomized, double-blind, placebo-controlled study », J Crohns Colitis, vol. 8, n^o 11,‎ novembre 2014, p. 1471–9 (PMID 24953836, DOI 10.1016/j.crohns.2014.05.009)
(en) « The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid », Aliment. Pharmacol. Ther., vol. 41, n^o 1,‎ janvier 2015, p. 54–64. (PMID 25329562, DOI 10.1111/apt.12999)

nice.org.uk

(en) NICE, « Bile acid malabsorption: colesevelam » (consulté le 17 aout 2014)

nih.gov

ncbi.nlm.nih.gov

(en) Hofmann, « The syndrome of ileal disease and the broken enterohepatic circulation: cholerheic enteropathy », Gastroenterology, vol. 52, n^o 4,‎ 1967, p. 752–7. (PMID 5337211)
(en) Thaysen et Pedersen, L, « Idiopathic bile acid catharsis », Gut, vol. 17, n^o 12,‎ 1976, p. 965–70 (PMID 1017717, PMCID 1411224, DOI 10.1136/gut.17.12.965)
(en) Fromm et Malavolti, M, « Bile acid-induced diarrhoea », Clinics in Gastroenterology, vol. 15, n^o 3,‎ 1986, p. 567–82. (PMID 3742841)
(en) Dawson, Lan, T et Rao, A, « Bile acid transporters », Journal of Lipid Research, vol. 50, n^o 12,‎ 2009, p. 2340–57. (PMID 19498215, PMCID 2781307, DOI 10.1194/jlr.R900012-JLR200)
(en) Oelkers, Kirby, LC, Heubi, JE et Dawson, PA, « Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2) », The Journal of Clinical Investigation, vol. 99, n^o 8,‎ 1997, p. 1880–7. (PMID 9109432, PMCID 508012, DOI 10.1172/JCI119355)
(en) Montagnani, Love, MW, Rössel, P et Dawson, PA, « Absence of dysfunctional ileal sodium-bile acid cotransporter gene mutations in patients with adult-onset idiopathic bile acid malabsorption », Scandinavian Journal of Gastroenterology, vol. 36, n^o 10,‎ 2001, p. 1077–80. (PMID 11589382, DOI 10.1080/003655201750422693)
(en) Hofmann, « Chronic diarrhea caused by idiopathic bile acid malabsorption: an explanation at last », Expert Review of Gastroenterology & Hepatology, vol. 3, n^o 5,‎ 2009, p. 461–4. (PMID 19817666, DOI 10.1586/egh.09.49)
(en) Walters, Tasleem, AM, Omer, O S et Brydon, WG, « A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis », Clinical Gastroenterology and Hepatology, vol. 7, n^o 11,‎ 2009, p. 1189–94. (PMID 19426836, DOI 10.1016/j.cgh.2009.04.024)
(en) van Tilburg, de Rooij, FW, van den Berg, JW et van Blankenstein, M, « Primary bile acid malabsorption: a pathophysiologic and clinical entity? », Scandinavian Journal of Gastroenterology. Supplement, vol. 194,‎ 1992, p. 66–70. (PMID 1298051)
(en) « Methods for diagnosis of bile acid malabsorption in clinical practice », Clin. Gastroenterol. Hepatol., vol. 11, n^o 10,‎ 2013, p. 1232–9. (PMID 23644387, PMCID 3783593, DOI 10.1016/j.cgh.2013.04.029)
(en) « Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome », Aliment. Pharmacol. Ther., vol. 30, n^o 7,‎ 2009, p. 707–17. (PMID 19570102, DOI 10.1111/j.1365-2036.2009.04081.x)
(en) Walters, « Defining primary bile acid diarrhea: making the diagnosis and recognizing the disorder », Expert Review of Gastroenterology & Hepatology, vol. 4, n^o 5,‎ 2010, p. 561–7. (PMID 20932141, DOI 10.1586/egh.10.54)
Khalid, Lalji, A, Stafferton, R et Andreyev, J, « Bile acid malabsorption: a forgotten diagnosis? », Clinical Medicine, vol. 10, n^o 2,‎ 2010, p. 124–6. (PMID 20437979, DOI 10.7861/clinmedicine.10-2-124)
(en) Brydon, Nyhlin, H, Eastwood, MA et Merrick, MV, « Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea », European Journal of Gastroenterology & Hepatology, vol. 8, n^o 2,‎ 1996, p. 117–23. (PMID 8723414, DOI 10.1097/00042737-199602000-00005)
(en) « Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention », Aliment. Pharmacol. Ther., vol. 38, n^o 8,‎ 2013, p. 967–76. (PMID 23981126, DOI 10.1111/apt.12466)
(en) Valentin, Camilleri, Altayar et Vijayvargiya, « Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis », Gut, vol. 65, n^o 12,‎ décembre 2016, p. 1951–9. (PMID 26347530, DOI 10.1136/gutjnl-2015-309889)
(en) « Systematic review: the management of chronic diarrhoea due to bile acid malabsorption », Aliment. Pharmacol. Ther., vol. 39, n^o 9,‎ mai 2014, p. 923–39. (PMID 24602022, DOI 10.1111/apt.12684)
(en) Wedlake, Thomas, K, Lalji, A et Anagnostopoulos, C, « Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire », Clinical Therapeutics, vol. 31, n^o 11,‎ 2009, p. 2549–58. (PMID 20109999, DOI 10.1016/j.clinthera.2009.11.027)
(en) « Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn's disease: A randomized, double-blind, placebo-controlled study », J Crohns Colitis, vol. 8, n^o 11,‎ novembre 2014, p. 1471–9 (PMID 24953836, DOI 10.1016/j.crohns.2014.05.009)
(en) « The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid », Aliment. Pharmacol. Ther., vol. 41, n^o 1,‎ janvier 2015, p. 54–64. (PMID 25329562, DOI 10.1111/apt.12999)